These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 17966882)

  • 1. [Serum arginase activity in patients with liver cirrhosis and hepatocellular carcinoma].
    Chrzanowska A; Mielczarek-Puta M; Skwarek A; Krawczyk M; Barańczyk-Kuźma A
    Wiad Lek; 2007; 60(5-6):215-8. PubMed ID: 17966882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum alpha-L-fucosidase activity and tumor size in hepatocellular carcinoma.
    Takahashi H; Saibara T; Iwamura S; Tomita A; Maeda T; Onishi S; Yamamoto Y; Enzan H
    Hepatology; 1994 Jun; 19(6):1414-7. PubMed ID: 7514563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum arginase activity in postsurgical monitoring of patients with colorectal carcinoma.
    Porembska Z; Skwarek A; Mielczarek M; Barańczyk-Kuźma A
    Cancer; 2002 Jun; 94(11):2930-4. PubMed ID: 12115381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of arginase determination in body fluids of patients with hepatocellular carcinoma and liver cirrhosis before and after surgical treatment.
    Chrzanowska A; Graboń W; Mielczarek-Puta M; Barańczyk-Kuźma A
    Clin Biochem; 2014 Aug; 47(12):1056-9. PubMed ID: 24713397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical course of chronic hepatitis C in patients with very high serum alpha-fetoprotein levels and normal hepatic imaging.
    Gonzalez SA; Jacobson IM
    Am J Gastroenterol; 2005 Apr; 100(4):977-8. PubMed ID: 15784045
    [No Abstract]   [Full Text] [Related]  

  • 6. Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma.
    Mao Y; Yang H; Xu H; Lu X; Sang X; Du S; Zhao H; Chen W; Xu Y; Chi T; Yang Z; Cai J; Li H; Chen J; Zhong S; Mohanti SR; Lopez-Soler R; Millis JM; Huang J; Zhang H
    Gut; 2010 Dec; 59(12):1687-93. PubMed ID: 20876776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Arginase as a marker of cancerogenesis. I. Monitoring patients after resection of colorectal cancer].
    Porembska Z; Mielczarek M; Nyckowski P; Barańczyk-Kuźma A
    Pol Merkur Lekarski; 2002 Oct; 13(76):284-5. PubMed ID: 12557431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Arginase a marker of cancerogenesis. II. Monitoring of patients after resection of colorectal liver metastases].
    Porembska Z; Nyckowski P; Skwarek A; Mielczarek M; Barańczyk-Kuźma A
    Pol Merkur Lekarski; 2002 Oct; 13(76):286-8. PubMed ID: 12557432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitin-proteasome profiling for enhanced detection of hepatocellular carcinoma in patients with chronic liver disease.
    Qu KZ; Zhang K; Ma W; Li H; Wang X; Zhang X; Giles F; Lai M; Afdhal NH; Albitar M
    J Gastroenterol Hepatol; 2011 Apr; 26(4):751-8. PubMed ID: 21418304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
    Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
    Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Change in alpha glutathione s-transferase levels during liver resection.
    Suehiro T; Matsumata T; Shikada Y; Shimada M; Shirabe K; Sugimachi K
    Hepatogastroenterology; 2004; 51(60):1747-50. PubMed ID: 15532818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum angiotensin converting enzyme in patients with primary liver carcinoma].
    Huskić J; Kulenović H; Kardum D; Babić N; Knezević Z
    Med Arh; 1999; 53(2):61-3. PubMed ID: 10386037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5'-Nucleotide phosphodiesterase isozyme-V in hepatocellular carcinoma and other liver diseases.
    Fujiyama S; Tsude K; Sakai M; Sato T
    Hepatogastroenterology; 1990 Oct; 37(5):469-73. PubMed ID: 1701410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Boronate affinity chromatography of gamma-glutamyltransferase in patients with hepatocellular carcinoma.
    Yamamoto T; Amuro Y; Matsuda Y; Nakaoka H; Shimomura S; Hada T; Higashino K
    Am J Gastroenterol; 1991 Apr; 86(4):495-9. PubMed ID: 1707223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum alpha-fetoprotein in chronic liver disease.
    Weisz G; Udvardy M; Dalmi L; Kulcsár A
    Acta Med Hung; 1983; 40(2-3):155-64. PubMed ID: 6199736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease.
    Zinkin NT; Grall F; Bhaskar K; Otu HH; Spentzos D; Kalmowitz B; Wells M; Guerrero M; Asara JM; Libermann TA; Afdhal NH
    Clin Cancer Res; 2008 Jan; 14(2):470-7. PubMed ID: 18223221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of alpha-fetoprotein-L3 using agglutinin-coupled spin column to be used in diagnosis of hepatocellular carcinoma].
    Sun GZ; Zhao XY; Li JH; Zhao GQ; Wang SX; Kong SL
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1986-8. PubMed ID: 19062741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of the serum measurement of alpha-L-fucosidase in the diagnosis of hepatocarcinoma].
    López Vivancos J; Segura RM; Oliva G; Vives L; Pascual C; Vilaseca J
    Med Clin (Barc); 1989 Sep; 93(7):241-3. PubMed ID: 2478845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Arginase as a marker of cancerogenesis. III. Comparison of arginase activity with CEA and Ca 19-9 in liver metastases of colorectal cancer].
    Porembska Z; Skwarek A; Chrzanowska A; Mielczarek M; Nyckowski P; Barańczyk-Kuźma A
    Pol Merkur Lekarski; 2004 Jan; 16(91):31-3. PubMed ID: 15074017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.